You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 33 No. 3, March 1976 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal

Infantile Diffuse Cerebral Degeneration With Hepatic Cirrhosis

Peter R. Huttenlocher, MD; Gilbert B. Solitare, MD; Gene Adams, MD

Arch Neurol. 1976;33(3):186-192.


Abstract

• Four children had progressive degeneration of the cerebral cortex, with hepatic cirrhosis. They and four previously described ones, are representative of a distinct form of hepatocerebral degeneration. Onset of the neurological disorder is between ages 1 and 3 years, at times with mild developmental delay. Explosive onset of intractable convulsions, leaving the child in a stuporous and demented state, is characteristic. Generalized hypotonia or hemiparesis were observed in several affected children. Clinical evidences of hepatic disease, including ascites and jaundice, occurred late, if at all. The illness ended fatally within ten months of onset of convulsions. Pathological findings in the brain are neuronal loss and gliosis, in a pattern that is indistinguishable from that in degeneration of the cerebral gray matter in infancy (Alpers disease). The hepatic lesions consist of cirrhosis or of subacute hepatitis, with superimposed fatty infiltration of hepatocytes. The disorder is genetically determined, with recessive inheritance.



Author Affiliations

From the departments of pediatrics and neurology (Dr Huttenlocher), and pathology (Dr Solitare), Yale University School of Medicine, New Haven, Conn. Dr Huttenlocher is now with the Department of Pediatrics, University of Chicago.


Footnotes

Accepted for publication Feb 6, 1975.

Reprint requests to Department of Pediatrics, University of Chicago, Box 228, 950 E 59th St, Chicago, IL 60637 (Dr Huttenlocher).



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Reversible valproate hepatotoxicity due to mutations in mitochondrial DNA polymerase {gamma} (POLG1)
McFarland et al.
Arch. Dis. Child. 2008;93:151-153.
ABSTRACT | FULL TEXT  

Juvenile Alpers Disease
Wiltshire et al.
Arch Neurol 2008;65:121-124.
ABSTRACT | FULL TEXT  

Recessive Twinkle mutations in early onset encephalopathy with mtDNA depletion
Hakonen et al.
Brain 2007;130:3032-3040.
ABSTRACT | FULL TEXT  

Infantile hepatocerebral syndromes associated with mutations in the mitochondrial DNA polymerase-{gamma}A
Ferrari et al.
Brain 2005;128:723-731.
ABSTRACT | FULL TEXT  

A Mutation in Mitochondrial DNA-Encoded Cytochrome c Oxidase II Gene in a Child With Alpers-Huttenlocher-Like Disease
Uusimaa et al.
Pediatrics 2003;111:e262-268.
ABSTRACT | FULL TEXT  

Current topic: Incidence, aetiology, and outcome of non-traumatic coma: a population based study
Wong et al.
Arch. Dis. Child. 2001;84:193-199.
ABSTRACT | FULL TEXT  

Review Article: Progressive Neuronal Degeneration of Childhood With Liver Disease (Alpers-Huttenlocher Syndrome): A Personal Review
Harding
J Child Neurol 1990;5:273-287.
ABSTRACT  

Progressive Neuronal Degeneration of Childhood (PNDC) with Liver Disease
Egger et al.
CLIN PEDIATR 1987;26:167-173.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1976 American Medical Association. All Rights Reserved.